Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market: Introduction

  • Platelet-rich plasma (PRP) is a blood product having an autologous property. It has a large number of platelets in a very minute quantity of plasma. The platelets, which are 2 mm diameter in size, are the cytoplasmic fragments of megakaryocytes developed in the marrow. More than 30 bioactive proteins are present in the platelets. These bioactive proteins are equipped with a vital role in tissue healing or hemostasis. Platelet-rich plasma contains three main proteins: fibrin, fibronectin, and vitronectin, which have an important role in cell adhesion molecules.
  • Differential centrifugation is a process used for the preparation of platelet-rich plasma. Acceleration force in differential centrifugation is used to centrifuge the constituents present in the blood to settle on different specific gravity. Centrifugation is acquired at different relative centrifugal time, force, and temperature. The two-step procedure yields the highest result.
  • Platelet-rich plasma functions as a fibrin tissue adhesive for hemostatic and tissue covering effects. It is not similar to fibrin glue or platelet-poor tissue adhesives, as the platelets have an ability to heal wounds and nourish osteogenesis. Biological isolation of platelet-rich plasma from whole blood is obtained for enriched platelets. Tissue regeneration, inflammatory response, promotion of angiogenesis, and infection control are improved with the help of high concentration of platelets in plasma.

Key Drivers, Restraints, and Opportunities of Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market

  • Acceleration of endothelial, epithelial, and epidermal regeneration, stimulation angiogenesis, development collagen synthesis, promotion of soft tissue healing, reduction of dermal scarring, development of hemostatic response to injuries, and adverse inhibition of wound healing caused by glucocorticoids are all processed by platelet-rich plasma. The higher the leukocyte concentration in platelet-rich plasma, the higher the antimicrobial effect. Platelet-rich plasma does not carry any risk of transmitting infectious disease. Thus, all these advantages fuel the market.
  • The concentrate of regenerative cells in bone marrow concentrate provides strong and healthy healing of the damaged tissue, enabling it to grow and repair by exceeding the body’s natural healing process. Bone marrow concentrate also relieves pain, reduces swelling, and boosts healing of articular cartilage and bone. All these factors are boosting the market.
  • Increased cases of orthopedic diseases and sports injuries along with significant expansion of the cosmetic surgery industry and increasing applications of the bone marrow aspirate concentrate (BMAC) products in orthopedic surgeries and cosmetic surgery is driving the platelet-rich plasma and bone marrow aspirate concentrate systems market.
  • Bone marrow aspirate concentrate is a cost-effective method to deliver mesenchymal stem cells, helping in the repair and regeneration of cartilage defects. This is expected to drive the platelet-rich plasma and bone marrow aspirate concentrate systems market during the forecast period. Platelet-rich plasma provides immediate surgical hemostatic agent, which is safe, biocompatible, and effective. Strong differences in platelet and growth factor concentrations among other blood products might affect the cell viability or gene expression. Platelet-rich plasma from male and female donors is expected to have significant differences in growth factor content between male and female platelet-rich plasma. This is anticipated to restrain the platelet-rich plasma and bone marrow aspirate concentrate systems market in the near future.

North America to Capture Major Share of Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market

North America accounted for the leading share of the market in 2020. It is expected to maintain its dominance of the platelet-rich plasma and bone marrow aspirate concentrate systems market during the forecast period. Furthermore, increasing incidences of osteoarthritis diseases, rising technological advancements, and awareness regarding stem cell therapy in the region is propelling the market.

Osteoarthritis (OA) is a widely prevalent joint disorder in the U.S., which occurs in almost 10% men and 13% in women of age 60 years or older. As per the Osteoarthritis Research Society International by 2030, approximately 67 million adults aged 18 years and older are expected to have doctor-diagnosed osteoarthritis. Additionally, increasing cases of osteoarthritis diseases and geriatric population in the country is fueling the market.

Key Players Operating in Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market

The global platelet-rich plasma and bone marrow aspirate concentrate systems market is highly fragmented, with the presence of various key players. A large number of manufacturers hold a major share in their respective regions. Major players operating in the global platelet-rich plasma and bone marrow aspirate concentrate systems market are:

  • Zimmer Biomet Holdings, Inc.
  • EmCyte Corporation
  • Cesca Therapeutics
  • AdiStem Ltd.
  • ISTO Biologics, Inc.
  • Stryker Corporation
  • Arthrex, Inc.
  • Harvest Technologies Corp. (Terumo Corporation)
  • DePuy Synthes
  • Regen Lab SA
  • Exactech, Inc.
  •  Nuo Therapeutics, Inc.
  • Aspire Medical Innovation
  • ThermoGenesis Corp.
  • Globus Medical, Inc
  • MED & CARE Innovative Solutions
  • MK Alliance Inc. (TotipotentSC)
  • Ranfac Corporation

Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market: Research Scope

Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market, by Type

  • Pure platelet-rich plasma
  • Leucocyte and platelet-rich plasma
  • Pure platelet-rich fibrin
  • Leucocyte and platelet-rich fibrin
  • Bone marrow aspirate concentrate systems.

Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market, by Origin

  • Allogeneic platelet-rich plasma
  • Autologous platelet-rich plasma
  • Homologous platelet-rich plasma
  • Bone marrow

Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market, by Application

  • Orthopedic surgery
  • Cosmetic surgery
  • General surgery
  • Wound Healing
  • Peripheral Vascular Disease
  • Blood Cancer
  • Others

Global Platelet-rich Plasma and Bone Marrow Aspirate Concentrate Systems Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Platelet-rich Plasma And Bone Marrow Aspirate Concentrate Systems Market